Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 80, Issue 5, Pages 1131-1138
Publisher
Wiley
Online
2015-04-28
DOI
10.1111/bcp.12667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans
- (2015) EK Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clopidogrel Bioactivation and Risk of Bleeding in Patients Cotreated With Angiotensin-Converting Enzyme Inhibitors After Myocardial Infarction: A Proof-of-Concept Study
- (2014) K E Kristensen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evaluation of the Inhibitory Effects of Antihypertensive Drugs on Human Carboxylesterase In Vitro
- (2013) Xu Yanjiao et al. Drug Metabolism and Pharmacokinetics
- Carboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans
- (2012) E K Tarkiainen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
- (2012) Joshua P. Lewis et al. Pharmacogenetics and Genomics
- Effect of Organic Anion-Transporting Polypeptide 1B1 (OATP1B1) Polymorphism on the Single- and Multiple-Dose Pharmacokinetics of Enalapril in Healthy Chinese Adult Men
- (2011) Lei Tian et al. CLINICAL THERAPEUTICS
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- In Vitro Evaluation of Inhibitory Effects of Antidiabetic and Antihyperlipidemic Drugs on Human Carboxylesterase Activities
- (2010) T. Fukami et al. DRUG METABOLISM AND DISPOSITION
- Carboxylesterase 1 (Ces1): from monocyte marker to major player
- (2010) G. M. Markey JOURNAL OF CLINICAL PATHOLOGY
- Common genetic variations of the renin–angiotensin–aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension
- (2010) Tuula Hannila-Handelberg et al. JOURNAL OF HYPERTENSION
- Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril
- (2009) Hao-Jie Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD
- (2009) Zsofia Nemoda et al. NEUROPHARMACOLOGY
- Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis
- (2008) Hao-Jie Zhu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
- (2008) H.-J. Zhu et al. DRUG METABOLISM AND DISPOSITION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now